IDEX (NYSE:IEX) Issues Quarterly Earnings Results

IDEX (NYSE:IEX) posted its earnings results on Wednesday. The industrial products company reported $2.32 EPS for the quarter, topping the consensus estimate of $2.11 by $0.21, FiscalAI reports. IDEX had a net margin of 14.38% and a return on equity of 15.29%. The company had revenue of $920.60 million during the quarter, compared to the consensus estimate of $905.38 million. During the same period in the previous year, the firm posted $2.07 earnings per share. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. IDEX updated its FY 2026 guidance to 8.700-8.850 EPS and its Q3 2026 guidance to 2.200-2.250 EPS.

Here are the key takeaways from IDEX’s conference call:

• Strong second-quarter performance: Organic sales grew 5%, adjusted EBITDA margin expanded 70 basis points to 28.1%, and adjusted EPS increased 12% to $2.32, excluding a $0.08 per-share benefit from IEEPA tariff refunds.
• Orders and backlog accelerated: Organic orders increased 28%, led by 47% growth in Health & Science Technologies (HST), with particular strength in data centers, semiconductors, and space and defense. Management said longer-dated orders are improving visibility into 2027 and beyond.
• IDEX raised its 2026 outlook, now expecting 5%-6% organic growth, adjusted EBITDA margins of 27%-27.3%, and adjusted EPS of $8.70-$8.85, versus prior EPS guidance of $8.35-$8.55.
• Performance was uneven across segments: HST revenue grew 12%, while Fluid & Metering Technologies (FMT) grew 1% and Fire & Safety/ 있다? Defense Products (FSDP) declined 1%; however, management cited early improvement in traditional short-cycle industrial demand and continued strength in water, mining, aerospace, and fire and safety.
• The company plans to increase 2026 capital expenditures to approximately $110 million, primarily to expand HST capacity for 2027-2028 demand, while maintaining roughly $75 million in quarterly share repurchases and retaining flexibility for bolt-on acquisitions.

IDEX Stock Performance

Shares of NYSE:IEX traded up $6.35 during midday trading on Wednesday, hitting $231.00. The company’s stock had a trading volume of 855,733 shares, compared to its average volume of 769,791. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.40 and a current ratio of 3.39. The stock’s 50 day simple moving average is $219.84 and its 200 day simple moving average is $207.73. The stock has a market capitalization of $17.10 billion, a price-to-earnings ratio of 34.17, a PEG ratio of 2.20 and a beta of 0.98. IDEX has a fifty-two week low of $157.25 and a fifty-two week high of $243.80.

IDEX Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, July 24th. Stockholders of record on Monday, July 6th were given a $0.73 dividend. This represents a $2.92 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend was Monday, July 6th. IDEX’s dividend payout ratio (DPR) is currently 43.20%.

Key Stories Impacting IDEX

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Quarterly results exceeded expectations. IDEX reported adjusted earnings of $2.32 per share, above the $2.11 consensus estimate and up from $2.07 a year earlier. Revenue reached $920.6 million, topping the $905.4 million estimate and increasing 6.4% year over year. IDEX quarterly earnings report
• Positive Sentiment: Demand indicators were particularly strong. Orders rose 29% on a reported basis, or 28% organically, to a record $1.07 billion. The company also reported $143.4 million in net income, compared with $131.6 million in the prior-year quarter, while diluted EPS increased 11% to $1.93. IDEX Q2 sales rise to record $921 million
• Positive Sentiment: Management raised its outlook. Full-year 2026 adjusted EPS guidance was set at $8.70–$8.85, above the $8.49 analyst consensus, while third-quarter guidance of $2.20–$2.25 also exceeded the $2.19 estimate. Full-year organic sales growth is projected at 5%–6%.
• Positive Sentiment: IDEX returned capital to shareholders through $77 million of share repurchases and $54 million in dividends, supporting the investment case.
• Neutral Sentiment: Analysts maintained an overall “Moderate Buy” consensus, while institutional ownership changes were mixed, with several large funds adding shares and others reducing or exiting positions. IDEX analyst recommendation
• Negative Sentiment: Insider activity was a modest caution: CEO Eric Ashleman sold 15,385 shares during the past six months and reported no purchases. The stock also trades at a relatively elevated valuation of roughly 34 times earnings, which could increase sensitivity to any slowdown.

Wall Street Analyst Weigh In

IEX has been the subject of a number of recent research reports. Citigroup upped their price objective on shares of IDEX from $243.00 to $252.00 and gave the stock a “buy” rating in a report on Thursday, April 30th. Stifel Nicolaus raised their target price on IDEX from $250.00 to $257.00 and gave the company a “buy” rating in a report on Monday, July 20th. TD Cowen upped their price target on IDEX from $250.00 to $260.00 and gave the stock a “buy” rating in a research note on Thursday, April 30th. Weiss Ratings raised IDEX from a “hold (c)” rating to a “hold (c+)” rating in a research note on Wednesday, June 24th. Finally, Seaport Research Partners reaffirmed a “buy” rating and set a $250.00 target price on shares of IDEX in a research report on Tuesday, May 5th. Six analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, IDEX presently has a consensus rating of “Moderate Buy” and a consensus price target of $244.00.

Insider Buying and Selling at IDEX

In related news, CEO Eric D. Ashleman sold 15,385 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $215.22, for a total transaction of $3,311,159.70. Following the completion of the sale, the chief executive officer owned 66,658 shares in the company, valued at $14,346,134.76. This represents a 18.75% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.50% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. CYBER HORNET ETFs LLC bought a new stake in shares of IDEX in the second quarter valued at approximately $35,000. MUFG Securities EMEA plc acquired a new stake in shares of IDEX in the second quarter worth $39,000. McMillan Office Inc. bought a new position in IDEX during the fourth quarter worth $46,000. Los Angeles Capital Management LLC acquired a new position in IDEX during the 4th quarter valued at $57,000. Finally, Employees Retirement System of Texas bought a new stake in IDEX in the 3rd quarter valued at $99,000. 97.96% of the stock is currently owned by institutional investors and hedge funds.

IDEX Company Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.